Advanced Enzyme Technologies
BSE: 540025 | NSE: ADVENZYMES | ISIN: INE837H01020 | SECTOR: Biotechnology & DrugsOpen
385.85High
393.00Low
385.40Prev Close
385.90P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
43.95BVolume
9.32KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
391.50Ask
-
Company Description
- Biotechnology & Drugs
BSE
540025NSE
ADVENZYMESISIN
INE837H01020
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
Company Officers
Beni Rauka
Chief Financial OfficerDipak Roda
Senior Vice President - Business Development, MarketingMukund Kabra
Whole Time DirectorMartina Doering
Managing Director and Head Of Business Development, evoxx technologies GmbH, GermanyHarshad Doshi
Chief Financial Officer and Chief Operating Officer of the US subsidiariesMichael Puls
Managing Director and Head Of Research and Development, evoxx technologies GmbH, GermanySanjay Basantani
Company Secretary, Head-Legal